FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

782373008: Amikacin liposome (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3753684019 Amikacin liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753685018 Amikacin liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amikacin liposome Is a Substance with aminoglycoside structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Amikacin liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Amikacin (substance) true Inferred relationship Some
Amikacin liposome This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Amikacin liposome Is a Liposomal agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Amikacin liposome only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amikacin liposome Inferred relationship Some 1
Product containing only amikacin liposome in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amikacin liposome Inferred relationship Some 1
Product containing amikacin liposome in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amikacin liposome Inferred relationship Some 1
Amikacin sulfate liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amikacin liposome Inferred relationship Some
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amikacin liposome Inferred relationship Some 1
Amikacin liposome-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amikacin liposome Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start